Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors

Mourad Chioua; Abdelouahid Samadi; Elena Soriano; Olivier Lozach; Laurent Meijer; José Marco-Contelles

doi:10.1016/j.bmcl.2009.06.099

Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors

Mourad Chioua
, Abdelouahid Samadi
, Elena Soriano
, Olivier Lozach
, Laurent Meijer
, José Marco-Contelles

Research output: Contribution to journal › Article › peer-review

100 Citations (Scopus)

Abstract

The synthesis and biological evaluation of a number of differently substituted 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives are reported. From the inhibition results on a selection of disease-relevant protein kinases [IC₅₀ (μM) DYRK1A = 11; CDK5 = 0.41; GSK-3 = 1.5] we have observed that 3,6-diamino-4-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (4) constitutes a potential new and simple lead compound in the search of drugs for the treatment of Alzheimer's disease.

Original language	English
Pages (from-to)	4566-4569
Number of pages	4
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	19
Issue number	16
DOIs	https://doi.org/10.1016/j.bmcl.2009.06.099
Publication status	Published - Aug 15 2009
Externally published	Yes

Keywords

3,6-Diamino-1H-pyrazolo[3,4-b]pyridine-5-carbonitriles
Alzheimer's disease
CDK5
GSK-3
Kinase inhibitors
Molecular modelling
Pyrazolo[3,4-b]pyridines

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmcl.2009.06.099

Cite this

@article{4083de4dffee4aeea2d80de3402f0220,

title = "Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors",

abstract = "The synthesis and biological evaluation of a number of differently substituted 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives are reported. From the inhibition results on a selection of disease-relevant protein kinases [IC50 (μM) DYRK1A = 11; CDK5 = 0.41; GSK-3 = 1.5] we have observed that 3,6-diamino-4-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (4) constitutes a potential new and simple lead compound in the search of drugs for the treatment of Alzheimer's disease.",

keywords = "3,6-Diamino-1H-pyrazolo[3,4-b]pyridine-5-carbonitriles, Alzheimer's disease, CDK5, GSK-3, Kinase inhibitors, Molecular modelling, Pyrazolo[3,4-b]pyridines",

author = "Mourad Chioua and Abdelouahid Samadi and Elena Soriano and Olivier Lozach and Laurent Meijer and Jos{\'e} Marco-Contelles",

note = "Funding Information: M.C. thanks Instituto de Salud Carlos III (Ministerio de Salud y Consumo) for a post-doctoral fellowship. AS thanks CSIC for a I3P Post-doctoral Contract. J.M.C. thanks also MEC (SAF2006-08764-C02-01), Comunidad de Madrid (S/SAL-0275-2006), and ISCIII [Retic RENEVAS (RD06/0026/1002)] for support. J.M.C. thanks Prof. A. Mart{\'i}nez (IQM, CSIC, Spain) for helpful suggestions and discussions. ",

year = "2009",

month = aug,

day = "15",

doi = "10.1016/j.bmcl.2009.06.099",

language = "English",

volume = "19",

pages = "4566--4569",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Ltd",

number = "16",

}

TY - JOUR

T1 - Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors

AU - Chioua, Mourad

AU - Samadi, Abdelouahid

AU - Soriano, Elena

AU - Lozach, Olivier

AU - Meijer, Laurent

AU - Marco-Contelles, José

N1 - Funding Information: M.C. thanks Instituto de Salud Carlos III (Ministerio de Salud y Consumo) for a post-doctoral fellowship. AS thanks CSIC for a I3P Post-doctoral Contract. J.M.C. thanks also MEC (SAF2006-08764-C02-01), Comunidad de Madrid (S/SAL-0275-2006), and ISCIII [Retic RENEVAS (RD06/0026/1002)] for support. J.M.C. thanks Prof. A. Martínez (IQM, CSIC, Spain) for helpful suggestions and discussions.

PY - 2009/8/15

Y1 - 2009/8/15

N2 - The synthesis and biological evaluation of a number of differently substituted 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives are reported. From the inhibition results on a selection of disease-relevant protein kinases [IC50 (μM) DYRK1A = 11; CDK5 = 0.41; GSK-3 = 1.5] we have observed that 3,6-diamino-4-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (4) constitutes a potential new and simple lead compound in the search of drugs for the treatment of Alzheimer's disease.

AB - The synthesis and biological evaluation of a number of differently substituted 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives are reported. From the inhibition results on a selection of disease-relevant protein kinases [IC50 (μM) DYRK1A = 11; CDK5 = 0.41; GSK-3 = 1.5] we have observed that 3,6-diamino-4-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (4) constitutes a potential new and simple lead compound in the search of drugs for the treatment of Alzheimer's disease.

KW - 3,6-Diamino-1H-pyrazolo[3,4-b]pyridine-5-carbonitriles

KW - Alzheimer's disease

KW - CDK5

KW - GSK-3

KW - Kinase inhibitors

KW - Molecular modelling

KW - Pyrazolo[3,4-b]pyridines

UR - https://www.scopus.com/pages/publications/67749116230

UR - https://www.scopus.com/pages/publications/67749116230#tab=citedBy

U2 - 10.1016/j.bmcl.2009.06.099

DO - 10.1016/j.bmcl.2009.06.099

M3 - Article

C2 - 19615897

AN - SCOPUS:67749116230

SN - 0960-894X

VL - 19

SP - 4566

EP - 4569

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 16

ER -

Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this